LivaNova PLC Logo

LivaNova PLC

LIVN

(2.2)
Stock Price

47,59 USD

-1.15% ROA

1.88% ROE

-170.36x PER

Market Cap.

2.826.210.900,00 USD

51.03% DER

0% Yield

1.91% NPM

LivaNova PLC Stock Analysis

LivaNova PLC Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

LivaNova PLC Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (50%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

ROE in an average range (0.24%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (0.25%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (2.06x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

6 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

7 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

8 Buffet Intrinsic Value

The company's stock seems undervalued (15.345) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

9 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

LivaNova PLC Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

LivaNova PLC Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

LivaNova PLC Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

LivaNova PLC Revenue
Year Revenue Growth
1993 100.000
1994 400.000 75%
1995 1.000.000 60%
1996 1.400.000 28.57%
1997 1.400.000 0%
1998 14.900.000 90.6%
1999 29.900.000 50.17%
2000 47.888.733 37.56%
2002 70.111.293 31.7%
2003 104.466.998 32.89%
2004 110.721.499 5.65%
2005 103.442.570 -7.04%
2006 123.441.575 16.2%
2007 130.968.437 5.75%
2008 121.229.742 -8.03%
2009 143.600.979 15.58%
2010 167.775.672 14.41%
2011 190.464.398 11.91%
2012 218.502.731 12.83%
2013 254.320.417 14.08%
2014 282.014.160 9.82%
2015 291.557.998 3.27%
2016 1.213.900.000 75.98%
2017 1.012.300.000 -19.92%
2018 1.107.000.000 8.55%
2019 1.084.200.000 -2.1%
2020 934.200.000 -16.06%
2021 1.035.400.000 9.77%
2022 1.021.800.000 -1.33%
2023 1.144.400.000 10.71%
2023 1.153.545.000 0.79%
2024 1.274.300.000 9.48%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

LivaNova PLC Research and Development Expenses
Year Research and Development Expenses Growth
1993 0
1994 0 0%
1995 0 0%
1996 8.000.000 100%
1997 6.500.000 -23.08%
1998 7.400.000 12.16%
1999 6.700.000 -10.45%
2000 8.037.096 16.64%
2002 24.516.547 67.22%
2003 17.874.909 -37.16%
2004 17.133.709 -4.33%
2005 19.341.075 11.41%
2006 29.541.707 34.53%
2007 28.092.243 -5.16%
2008 22.421.199 -25.29%
2009 19.732.941 -13.62%
2010 22.064.800 10.57%
2011 28.602.684 22.86%
2012 35.334.770 19.05%
2013 41.551.444 14.96%
2014 46.562.775 10.76%
2015 43.284.432 -7.57%
2016 122.500.000 64.67%
2017 109.700.000 -11.67%
2018 146.000.000 24.86%
2019 149.900.000 2.6%
2020 152.900.000 1.96%
2021 183.400.000 16.63%
2022 155.800.000 -17.72%
2023 186.000.000 16.24%
2023 166.017.000 -12.04%
2024 178.948.000 7.23%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

LivaNova PLC General and Administrative Expenses
Year General and Administrative Expenses Growth
1993 0
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

LivaNova PLC EBITDA
Year EBITDA Growth
1993 -5.700.000
1994 -6.900.000 17.39%
1995 -8.300.000 16.87%
1996 -10.500.000 20.95%
1997 -11.300.000 7.08%
1998 -17.500.000 35.43%
1999 -12.700.000 -37.8%
2000 -3.756.909 -238.04%
2002 -23.015.876 83.68%
2003 9.231.332 349.32%
2004 11.222.133 17.74%
2005 -9.003.235 224.65%
2006 -54.813.687 83.57%
2007 -44.725.035 -22.56%
2008 -3.872.196 -1055.03%
2009 22.405.365 117.28%
2010 36.954.474 39.37%
2011 49.449.941 25.27%
2012 61.268.971 19.29%
2013 80.032.297 23.44%
2014 92.944.084 13.89%
2015 113.290.431 17.96%
2016 243.800.000 53.53%
2017 211.300.000 -15.38%
2018 156.200.000 -35.28%
2019 131.000.000 -19.24%
2020 38.500.000 -240.26%
2021 67.000.000 42.54%
2022 110.500.000 39.37%
2023 78.400.000 -40.94%
2023 159.809.000 50.94%
2024 235.216.000 32.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

LivaNova PLC Gross Profit
Year Gross Profit Growth
1993 200.000
1994 600.000 66.67%
1995 1.000.000 40%
1996 1.200.000 16.67%
1997 1.300.000 7.69%
1998 11.700.000 88.89%
1999 23.700.000 50.63%
2000 37.504.559 36.81%
2002 56.494.919 33.61%
2003 88.400.769 36.09%
2004 94.425.937 6.38%
2005 87.866.829 -7.46%
2006 107.619.530 18.35%
2007 112.710.063 4.52%
2008 100.137.368 -12.56%
2009 123.560.343 18.96%
2010 146.868.077 15.87%
2011 167.444.366 12.29%
2012 198.846.399 15.79%
2013 232.413.153 14.44%
2014 254.659.269 8.74%
2015 264.247.129 3.63%
2016 704.400.000 62.49%
2017 651.600.000 -8.1%
2018 734.500.000 11.29%
2019 744.800.000 1.38%
2020 618.200.000 -20.48%
2021 706.000.000 12.44%
2022 707.200.000 0.17%
2023 807.200.000 12.39%
2023 785.450.000 -2.77%
2024 881.460.000 10.89%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

LivaNova PLC Net Profit
Year Net Profit Growth
1993 -5.100.000
1994 -5.900.000 13.56%
1995 -7.200.000 18.06%
1996 -10.100.000 28.71%
1997 -11.200.000 9.82%
1998 -14.200.000 21.13%
1999 -12.500.000 -13.6%
2000 -3.053.244 -309.4%
2002 -26.119.905 88.31%
2003 5.184.931 603.77%
2004 6.759.509 23.29%
2005 -12.218.348 155.32%
2006 -59.069.192 79.32%
2007 -51.180.107 -15.41%
2008 -10.334.765 -395.22%
2009 26.720.620 138.68%
2010 78.448.884 65.94%
2011 46.725.710 -67.89%
2012 36.077.732 -29.51%
2013 46.357.502 22.17%
2014 54.890.257 15.55%
2015 57.847.534 5.11%
2016 -62.800.000 192.11%
2017 -25.100.000 -150.2%
2018 -189.400.000 86.75%
2019 -155.500.000 -21.8%
2020 -343.300.000 54.7%
2021 -135.700.000 -152.98%
2022 -86.200.000 -57.42%
2023 -29.200.000 -195.21%
2023 17.546.000 266.42%
2024 65.332.000 73.14%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

LivaNova PLC Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1993 -1
1994 -1 0%
1995 -1 0%
1996 -1 100%
1997 -1 0%
1998 -1 0%
1999 -1 0%
2000 0 0%
2002 -1 100%
2003 0 0%
2004 0 0%
2005 -1 0%
2006 -2 100%
2007 -2 0%
2008 0 0%
2009 1 100%
2010 3 50%
2011 2 -100%
2012 1 0%
2013 2 0%
2014 2 50%
2015 2 0%
2016 -1 300%
2017 -1 0%
2018 -4 100%
2019 -3 0%
2020 -7 57.14%
2021 -3 -250%
2022 -2 -100%
2023 -1 0%
2023 0 0%
2024 1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

LivaNova PLC Free Cashflow
Year Free Cashflow Growth
1993 -5.100.000
1994 -6.000.000 15%
1995 -6.600.000 9.09%
1996 -9.700.000 31.96%
1997 -12.300.000 21.14%
1998 -18.300.000 32.79%
1999 -16.400.000 -11.59%
2000 -12.290.357 -33.44%
2002 -28.033.822 56.16%
2003 -2.931.062 -856.44%
2004 994.757 394.65%
2005 -7.683.309 112.95%
2006 -75.175.068 89.78%
2007 -22.114.205 -239.94%
2008 13.638.143 262.15%
2009 21.921.684 37.79%
2010 36.762.879 40.37%
2011 42.485.107 13.47%
2012 57.042.063 25.52%
2013 64.748.313 11.9%
2014 35.134.376 -84.29%
2015 72.988.527 51.86%
2016 53.000.000 -37.71%
2017 57.200.000 7.34%
2018 82.500.000 30.67%
2019 -119.100.000 169.27%
2020 -114.400.000 -4.11%
2021 77.000.000 248.57%
2022 43.400.000 -77.42%
2023 39.933.000 -8.68%
2023 9.400.000 -324.82%
2024 31.200.000 69.87%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

LivaNova PLC Operating Cashflow
Year Operating Cashflow Growth
1993 -4.800.000
1994 -5.600.000 14.29%
1995 -6.300.000 11.11%
1996 -9.600.000 34.38%
1997 -12.000.000 20%
1998 -14.800.000 18.92%
1999 -14.700.000 -0.68%
2000 -8.175.537 -79.8%
2002 -22.951.390 64.38%
2003 1.275.666 1899.17%
2004 3.595.349 64.52%
2005 -3.969.672 190.57%
2006 -70.876.209 94.4%
2007 -20.688.856 -242.58%
2008 14.455.207 243.12%
2009 24.589.950 41.21%
2010 42.885.486 42.66%
2011 49.872.107 14.01%
2012 75.026.165 33.53%
2013 79.053.759 5.09%
2014 54.195.816 -45.87%
2015 79.675.116 31.98%
2016 90.200.000 11.67%
2017 91.300.000 1.2%
2018 120.500.000 24.23%
2019 -91.100.000 232.27%
2020 -79.400.000 -14.74%
2021 102.500.000 177.46%
2022 69.900.000 -46.64%
2023 74.914.000 6.69%
2023 18.200.000 -311.62%
2024 43.356.000 58.02%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

LivaNova PLC Capital Expenditure
Year Capital Expenditure Growth
1993 300.000
1994 400.000 25%
1995 300.000 -33.33%
1996 100.000 -200%
1997 300.000 66.67%
1998 3.500.000 91.43%
1999 1.700.000 -105.88%
2000 4.114.820 58.69%
2002 5.082.432 19.04%
2003 4.206.728 -20.82%
2004 2.600.592 -61.76%
2005 3.713.637 29.97%
2006 4.298.859 13.61%
2007 1.425.349 -201.6%
2008 817.064 -74.45%
2009 2.668.266 69.38%
2010 6.122.607 56.42%
2011 7.387.000 17.12%
2012 17.984.102 58.92%
2013 14.305.446 -25.72%
2014 19.061.440 24.95%
2015 6.686.589 -185.07%
2016 37.200.000 82.03%
2017 34.100.000 -9.09%
2018 38.000.000 10.26%
2019 28.000.000 -35.71%
2020 35.000.000 20%
2021 25.500.000 -37.25%
2022 26.500.000 3.77%
2023 34.981.000 24.24%
2023 8.800.000 -297.51%
2024 12.156.000 27.61%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

LivaNova PLC Equity
Year Equity Growth
1993 24.100.000
1994 18.500.000 -30.27%
1995 11.400.000 -62.28%
1996 1.500.000 -660%
1997 8.400.000 82.14%
1998 44.700.000 81.21%
1999 33.400.000 -33.83%
2000 38.407.975 13.04%
2001 59.647.084 35.61%
2002 36.613.813 -62.91%
2003 48.512.003 24.53%
2004 68.980.479 29.67%
2005 75.595.841 8.75%
2006 4.629.866 -1532.79%
2007 -16.062.229 128.82%
2008 -15.223.305 -5.51%
2009 24.411.844 162.36%
2010 110.859.647 77.98%
2011 175.453.350 36.82%
2012 183.469.370 4.37%
2013 229.568.228 20.08%
2014 259.099.844 11.4%
2014 259.099.844 0%
2015 1.811.462.000 85.7%
2016 1.706.900.000 -6.13%
2017 1.815.300.000 5.97%
2018 1.503.700.000 -20.72%
2019 1.383.700.000 -8.67%
2020 1.118.800.000 -23.68%
2021 1.294.600.000 13.58%
2022 1.207.600.000 -7.2%
2023 1.225.500.000 1.46%
2023 1.277.628.000 4.08%
2024 1.242.542.000 -2.82%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

LivaNova PLC Assets
Year Assets Growth
1993 25.200.000
1994 19.800.000 -27.27%
1995 13.600.000 -45.59%
1996 3.900.000 -248.72%
1997 10.200.000 61.76%
1998 52.600.000 80.61%
1999 39.800.000 -32.16%
2000 44.604.045 10.77%
2001 78.314.924 43.05%
2002 64.322.876 -21.75%
2003 74.954.731 14.18%
2004 94.296.524 20.51%
2005 98.855.397 4.61%
2006 152.300.284 35.09%
2007 137.644.883 -10.65%
2008 136.231.087 -1.04%
2009 112.043.628 -21.59%
2010 155.763.977 28.07%
2011 211.469.205 26.34%
2012 211.908.195 0.21%
2013 264.043.310 19.74%
2014 294.191.394 10.25%
2014 294.191.394 0%
2015 2.558.739.000 88.5%
2016 2.342.600.000 -9.23%
2017 2.503.900.000 6.44%
2018 2.549.700.000 1.8%
2019 2.411.800.000 -5.72%
2020 2.411.400.000 -0.02%
2021 2.201.000.000 -9.56%
2022 2.294.800.000 4.09%
2023 2.329.400.000 1.49%
2023 2.429.563.000 4.12%
2024 2.453.188.000 0.96%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

LivaNova PLC Liabilities
Year Liabilities Growth
1993 1.100.000
1994 1.300.000 15.38%
1995 2.200.000 40.91%
1996 2.400.000 8.33%
1997 1.800.000 -33.33%
1998 7.900.000 77.22%
1999 6.400.000 -23.44%
2000 6.196.070 -3.29%
2001 18.667.840 66.81%
2002 27.709.063 32.63%
2003 26.442.728 -4.79%
2004 25.316.045 -4.45%
2005 23.259.556 -8.84%
2006 147.670.418 84.25%
2007 153.707.112 3.93%
2008 151.454.392 -1.49%
2009 87.631.784 -72.83%
2010 44.904.330 -95.15%
2011 36.015.855 -24.68%
2012 28.438.825 -26.64%
2013 34.475.082 17.51%
2014 35.091.550 1.76%
2014 35.091.550 0%
2015 747.277.000 95.3%
2016 635.700.000 -17.55%
2017 688.600.000 7.68%
2018 1.046.000.000 34.17%
2019 1.028.100.000 -1.74%
2020 1.292.600.000 20.46%
2021 906.400.000 -42.61%
2022 1.087.200.000 16.63%
2023 1.103.900.000 1.51%
2023 1.151.935.000 4.17%
2024 1.210.646.000 4.85%

LivaNova PLC Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
22.3
Net Income per Share
-0.31
Price to Earning Ratio
-170.36x
Price To Sales Ratio
2.34x
POCF Ratio
22.5
PFCF Ratio
33.16
Price to Book Ratio
2.27
EV to Sales
2.37
EV Over EBITDA
67.69
EV to Operating CashFlow
22.87
EV to FreeCashFlow
33.68
Earnings Yield
-0.01
FreeCashFlow Yield
0.03
Market Cap
2,83 Bil.
Enterprise Value
2,87 Bil.
Graham Number
12.55
Graham NetNet
-6.44

Income Statement Metrics

Net Income per Share
-0.31
Income Quality
-7.55
ROE
-0.01
Return On Assets
0.01
Return On Capital Employed
0.02
Net Income per EBT
-0.38
EBT Per Ebit
-1.89
Ebit per Revenue
0.03
Effective Tax Rate
1.38

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.15
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.68
Operating Profit Margin
0.03
Pretax Profit Margin
-0.05
Net Profit Margin
0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
2.31
Free CashFlow per Share
1.57
Capex to Operating CashFlow
0.32
Capex to Revenue
0.03
Capex to Depreciation
0.71
Return on Invested Capital
0
Return on Tangible Assets
-0.01
Days Sales Outstanding
60.61
Days Payables Outstanding
76.75
Days of Inventory on Hand
146.03
Receivables Turnover
6.02
Payables Turnover
4.76
Inventory Turnover
2.5
Capex per Share
0.74

Balance Sheet

Cash per Share
11,67
Book Value per Share
22,91
Tangible Book Value per Share
4.2
Shareholders Equity per Share
22.91
Interest Debt per Share
12.26
Debt to Equity
0.51
Debt to Assets
0.26
Net Debt to EBITDA
1.05
Current Ratio
3.45
Tangible Asset Value
0,23 Bil.
Net Current Asset Value
-0,16 Bil.
Invested Capital
1966058000
Working Capital
0,74 Bil.
Intangibles to Total Assets
0.41
Average Receivables
0,21 Bil.
Average Payables
0,08 Bil.
Average Inventory
153949000
Debt to Market Cap
0.22

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

LivaNova PLC Dividends
Year Dividends Growth

LivaNova PLC Profile

About LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

CEO
Mr. Vladimir A. Makatsaria
Employee
2.900
Address
20 Eastbourne Terrace
London, W2 6LG

LivaNova PLC Executives & BODs

LivaNova PLC Executives & BODs
# Name Age
1 Mr. Franco Poletti
President of Cardiopulmonary Business Unit
70
2 Deanna Wilke
Vice President of Corporate Communications
70
3 Mr. Philip Kowalczyk
Chief Strategy & Corporate Development Officer
70
4 Ms. Stephanie Bolton
President of Global Epilepsy
70
5 Mr. Paul R. Buckman
President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement
70
6 Mr. Vladimir A. Makatsaria
Chief Executive Officer & Director
70
7 Ms. Lindsey Little
Senior Director of Investor Relations
70
8 Ahmet Tezel Ph.D.
Chief Innovation Officer
70
9 Mr. Alex Shvartsburg C.M.A.
Chief Financial Officer
70
10 Mr. Michael D. Hutchinson
Senior Vice President, Chief Legal Officer & Company Secretary
70

LivaNova PLC Competitors